Document is current
Any future updates will be listed below
-
Authors
Brenner, Charles https://orcid.org/0000-0002-4955-3226
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HL147545)
- License Information
-
More Information
Article History
First Online: 3 January 2022
Competing interests
: C.B. developed intellectual property on nutritional and therapeutic uses of NR, which were commercialized by ChromaDex. C.B. owns ChromaDex stock and serves as their chief scientific advisor.
Free to read: This content has been made available to all.
